Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Melanoma 2 Glioblastoma 2 Brain Neoplasms 2 Advanced Solid Tumor 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Ulnar Neuropathies 1 Triple Negative Breast Neoplasms 1 Solid Tumor, Adult 1 Prostatic Hyperplasia 1 Peripheral Lung Tumor 1 Pain 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Squamous Lung Cancer 1 Neuroma 1 Multiple Myeloma 1 Mucositis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leiomyoma 1 Keratosis, Actinic 1 Hyperthermia 1 Glioma 1

Interventions

3-ingenyl angelate 33 Imiquimod 18 Aminolevulinic Acid 16 Gels 10 Diclofenac 10 Photochemotherapy 7 methyl 5-aminolevulinate 6 Fluorouracil 6 Solutions 5 LEO 43204 5 BF-200 ALA 5 tirbanibulin 4 Ointments 4 Cryotherapy 3 SR-T100 2 potassium dobesilate 1 green tea extract polyphenone E 1 beta-solamarine 1 afamelanotide 1 Therapies, Investigational 1 Therapeutics 1 Petrolatum 1 Excipients 1 Drugs, Generic 1 Cryosurgery 1 Control Groups 1 AVX001 1 5-fluorouracil, salicylic acid drug combination 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Keratosis, Actinic × Therapeutics × Clear all

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡